The DOI matches its Crossref record.
THE NATURAL DURATION OF CANCER
Open accessAbstract
IN every instance where the value of a method of treatment in disease is under consideration a basis of comparison derived from observations in which no special treatment is applied is necessary.Sometimes, as in the case of acute intestinal obstruction and operation, or in that of diabetic coma and insulin, the comparison is sharply defined between
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma
Yu, A. L., Gilman, A. L., Ozkaynak, M. F., London, W. B., Kreissman, S. G., Chen, H. X., Smith, M., Anderson, B., Villablanca, J. G., Matthay, K. K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0911123 · Cited by 1,835
Zeng, H., Chen, W., Zheng, R., Zhang, S., Ji, J. S., Zou, X., Xia, C., Sun, K., Yang, Z., Li, H., et al. (2018) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30127-x · Cited by 1,546
Rizvi, N. A., Mazières, J., Planchard, D., Stinchcombe, T. E., Dy, G. K., Antonia, S. J., Horn, L., Lena, H., Minenza, E., Mennecier, B., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)70054-9 · Cited by 1,415
(1983) · Circulation · doi:10.1161/01.cir.68.5.939 · Cited by 1,199
Cancer survival in five continents: a worldwide population-based study (CONCORD)
Coleman, M. P., Quaresma, M., Berrino, F., Lutz, J.-M., De Angelis, R., Capocaccia, R., Baili, P., Rachet, B., Gatta, G., Hakulinen, T., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70179-7 · Cited by 1,002
A Confidence Interval for the Median Survival Time
Brookmeyer, R., & Crowley, J. (1982) · Biometrics · doi:10.2307/2530286 · Cited by 914
Long-Term Mortality after Screening for Colorectal Cancer
Shaukat, A., Mongin, S. J., Geisser, M. S., Lederle, F. A., Bond, J. H., Mandel, J. S., & Church, T. R. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1300720 · Cited by 850
A Large Sample Study of the Life Table and Product Limit Estimates Under Random Censorship
Breslow, N., & Crowley, J. (1974) · The Annals of Statistics · doi:10.1214/aos/1176342705 · Cited by 728
Sharma, P., Callahan, M. K., Bono, P., Kim, J., Spiliopoulou, P., Calvo, E., Pillai, R. N., Ott, P. A., de Braud, F., Morse, M., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30496-x · Cited by 678
Cancer survival in China, 2003–2005: A population‐based study
Zeng, H., Zheng, R., Guo, Y., Zhang, S., Zou, X., Wang, N., Zhang, L., Tang, J., Chen, J., Wei, K., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29227 · Cited by 622
Cyclin E and Survival in Patients with Breast Cancer
Keyomarsi, K., Tucker, S. L., Buchholz, T. A., Callister, M., Ding, Y., Hortobagyi, G. N., Bedrosian, I., Knickerbocker, C., Toyofuku, W., Lowe, M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021153 · Cited by 557
Quality assessment of 26 304 herniorrhaphies in Denmark: a prospective nationwide study
Bay-Nielsen, M., Kehlet, H., Strand, L., Malmstrøm, J., Andersen, F. H., Wara, P., Juul, P., & Callesen, T. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06251-1 · Cited by 536
Nivolumab Monotherapy for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer
Gettinger, S., Rizvi, N. A., Chow, L. Q., Borghaei, H., Brahmer, J., Ready, N., Gerber, D. E., Shepherd, F. A., Antonia, S., Goldman, J. W., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.66.9929 · Cited by 501
Improved Estimates of Cancer-Specific Survival Rates From Population-Based Data
Howlader, N., Ries, L. A. G., Mariotto, A. B., Reichman, M. E., Ruhl, J., & Cronin, K. A. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq366 · Cited by 452
Raut, C. P., Posner, M., Desai, J., Morgan, J. A., George, S., Zahrieh, D., Fletcher, C. D. M., Demetri, G. D., & Bertagnolli, M. M. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.3439 · Cited by 448
Rizvi, N. A., Hellmann, M. D., Brahmer, J. R., Juergens, R. A., Borghaei, H., Gettinger, S., Chow, L. Q., Gerber, D. E., Laurie, S. A., Goldman, J. W., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.66.9861 · Cited by 445
Progression-free rate as the principal end-point for phase II trials in soft-tissue sarcomas
Van Glabbeke, M., Verweij, J., Judson, I., & Nielsen, O. S. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00398-7 · Cited by 424
Douillard, J.-Y., Ostoros, G., Cobo, M., Ciuleanu, T., McCormack, R., Webster, A., & Milenkova, T. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.721 · Cited by 412
Rapiti, E., Verkooijen, H. M., Vlastos, G., Fioretta, G., Neyroud-Caspar, I., Sappino, A. P., Chappuis, P. O., & Bouchardy, C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.2226 · Cited by 391
How persistently do firms innovate?
Geroski, P. A., Van Reenen, J., & Walters, C. F. (1997) · Research Policy · doi:10.1016/s0048-7333(96)00903-1 · Cited by 389
Tabernero, J., Van Cutsem, E., Díaz-Rubio, E., Cervantes, A., Humblet, Y., André, T., Van Laethem, J.-L., Soulié, P., Casado, E., Verslype, C., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.2183 · Cited by 337
Woods, W., Kobrinsky, N., Buckley, J., Lee, J., Sanders, J., Neudorf, S., Gold, S., Barnard, D., DeSwarte, J., Dusenbery, K., et al. (1996) · Blood · doi:10.1182/blood.v87.12.4979.bloodjournal87124979 · Cited by 329
Kreissman, S. G., Seeger, R. C., Matthay, K. K., London, W. B., Sposto, R., Grupp, S. A., Haas-Kogan, D. A., LaQuaglia, M. P., Yu, A. L., Diller, L., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70309-7 · Cited by 304
Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?
Aebi, S., Gelber, S., Castiglione-Gertsch, M., Gelber, R., Collins, J., Thürlimann, B., Rudenstam, C., Lindtner, J., Crivellari, D., Cortes-Funes, H., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02292-3 · Cited by 287
Confidence bands for a survival curve from censored data
HALL, W. J., & WELLNER, J. A. (1980) · Biometrika · doi:10.1093/biomet/67.1.133 · Cited by 287
A method for measuring and modeling the physiological traits causing obstructive sleep apnea
Wellman, A., Eckert, D. J., Jordan, A. S., Edwards, B. A., Passaglia, C. L., Jackson, A. C., Gautam, S., Owens, R. L., Malhotra, A., & White, D. P. (2011) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00972.2010 · Cited by 283
Klein, J., Rizzo, J., Zhang, M.-J., & Keiding, N. (2001) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1703260 · Cited by 278
International Breast Cancer Study Group (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg119 · Cited by 264
Berclaz, G., Li, S., Price, K. N., Coates, A. S., Castiglione-Gertsch, M., Rudenstam, C.-M., Holmberg, S. B., Lindtner, J., Erien, D., Collins, J., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh222 · Cited by 257
Henson, D. E., Ries, L., Freedman, L. S., & Carriaga, M. (1991) · Cancer · doi:10.1002/1097-0142(19911115)68:10<2142::aid-cncr2820681010>3.0.co;2-d · Cited by 253
Fusar-Poli, P., Rutigliano, G., Stahl, D., Davies, C., Bonoldi, I., Reilly, T., & McGuire, P. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.0284 · Cited by 246
Rubin, R. R., Ma, Y., Marrero, D. G., Peyrot, M., Barrett-Connor, E. L., Kahn, S. E., Haffner, S. M., Price, D. W., Knowler, W. C., & for the Diabetes Prevention Program Research Group (2008) · Diabetes Care · doi:10.2337/dc07-1827 · Cited by 242
Fusar-Poli, P., Rutigliano, G., Stahl, D., Schmidt, A., Ramella-Cravaro, V., Hitesh, S., & McGuire, P. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.2707 · Cited by 121
Fusar-Poli, P., Werbeloff, N., Rutigliano, G., Oliver, D., Davies, C., Stahl, D., McGuire, P., & Osborn, D. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sby070 · Cited by 95
The use of intermediate endpoints in the design of type 1 diabetes prevention trials
the Type 1 Diabetes TrialNet Study Group, & Krischer, J. P. (2013) · Diabetologia · doi:10.1007/s00125-013-2960-7 · Cited by 64
Oliver, D., Spada, G., Colling, C., Broadbent, M., Baldwin, H., Patel, R., Stewart, R., Stahl, D., Dobson, R., McGuire, P., et al. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2020.05.007 · Cited by 49
“The cumulative incidence of psychosis was measured with Kaplan-Meier curves and 95% Greenwood confidence intervals (Lazarus-Barlow and Leeming, 1924), and log-rank test.”
Estimating a population cumulative incidence under calendar time trends
Hansen, S. N., Overgaard, M., Andersen, P. K., & Parner, E. T. (2017) · BMC Medical Research Methodology · doi:10.1186/s12874-016-0280-6 · Cited by 24
Metadata
- Authors
- Lazarus-Barlow, W. S., & Leeming, J. H.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1924-08-16
- Volume
- 2
- Issue
- 3320
- Pages
- 266-267
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2095002555
- Cited by
- 427
- References
- 0
- FWCI
- 3.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.